1. Home
  2. AVGR

as 02-04-2025 2:31pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.

Founded: 2007 Country:
United States
United States
Employees: N/A City: REDWOOD CITY
Market Cap: 2.6M IPO Year: 2015
Target Price: $5.00 AVG Volume (30 days): 877.5K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -6.23 EPS Growth: N/A
52 Week Low/High: $0.39 - $5.45 Next Earning Date: 03-19-2025
Revenue: $7,262,000 Revenue Growth: -6.26%
Revenue Growth (this year): -4.03% Revenue Growth (next year): 93.49%

AVGR Daily Stock ML Predictions

Stock Insider Trading Activity of Avinger Inc. (AVGR)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Patel Himanshu AVGR Chief Technology Officer Jan 23 '25 Sell $0.56 2,215 $1,233.09 39,062
Subainati Nabeel Paul AVGR Vice President, Finance Jan 23 '25 Sell $0.56 1,255 $698.66 3,296

Share on Social Networks: